Exactech, Inc. 

(Public, NASDAQ:EXAC)   Watch this stock   
Find more results for EXAC
Oct 28, 2009
Q3 2009 Earnings Conference Call
Oct 27, 2009
Q3 2009 Earnings Release
Sep 21, 2009
UBS Global Life Sciences Conference
Sep 10, 2009
Thomas Weisel Partners Healthcare Conference
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 6.47% 6.86%
Operating margin 10.41% 11.47%
EBITD margin - 16.74%
Return on average assets 6.37% 7.81%
Return on average equity 8.52% 10.60%
Employees 390 -

Address

2320 NW 66th Court
Gainesville, FL 32653
United States - Map
+1-352-3771140 (Phone)
+1-352-3782617 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com
Discussion Group - Google Finance

Exactech, Inc. discussed on blogs

Ranking 1100+ Micro Cap Stocks by Upside Potential - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 20, 2009

Description

Exactech, Inc. (Exactech) develops, manufactures, markets, distributes and sells orthopaedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians in the United States and internationally. The Company’s revenues are principally derived from sales and distribution of its joint replacement systems, including knee, hip, spine and implant systems, and distribution of biologic products and services and bone cement materials used in orthopaedic surgery and dental procedures. Exactech manufactures some components of its knee, extremity and hip joint replacement systems at its facility in Gainesville, Florida utilizing automated computer aided manufacturing equipment. Its cellular based manufacturing processes, which are organized in groups, or cells, are focused on specific product lines. Additionally, the Company acquires and distributes other products and services through agreements, with Tecres S.p.A, RTI Biologics, Inc. and Biomatlante SARL.

Officers and directors

William Petty M.D.
Chairman of the Board, Chief Executive Officer
Age: 66
Bio & Compensation - Reuters
David W. Petty
President, Director
Age: 42
Bio & Compensation - Reuters
Joel C. Phillips CPA
Chief Financial Officer, Treasurer
Age: 41
Bio & Compensation - Reuters
Gary J. Miller Ph.D.
Executive Vice President - Research and Development
Age: 61
Bio & Compensation - Reuters
Bruce Thompson
Senior Vice President, General Manager - – Biologics and Spine Division
Age: 51
Bio & Compensation - Reuters
Betty A. Petty
Vice President - Administration and Human Resources, Corporate Secretary
Age: 66
Bio & Compensation - Reuters
Albert Burstein Ph.D.
Director
Age: 71
Bio & Compensation - Reuters
R. Wynn Kearney Jr.
Director
Age: 65
Bio & Compensation - Reuters
Paul E. Metts CPA.
Director
Age: 66
Bio & Compensation - Reuters
William B. Locander Ph.D.
Director
Age: 65
Bio & Compensation - Reuters